Navigation Links
Pharmasset to Present at Two Upcoming Investor Conferences
Date:3/30/2009

ults of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2008 and our Quarterly Report on Form 10-Q for the period ended December 31, 2008 filed with the Securities and Exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pharmassets Underwriters Release Shares from Lock-Up
2. Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
3. Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
4. Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th
5. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
6. Pharmasset to Webcast an Investor Event from the AASLD Meeting
7. Pharmasset to Present at the 27th Annual JPMorgan Healthcare Conference
8. Pharmasset to Present at Two Upcoming Investor Conferences
9. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
10. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
11. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... GENEVA, IL (PRWEB) , ... September 04, 2015 , ... ... in Geneva, IL hosting Generation Rescue’s A Night of Hope event supporting families affected ... Ed French and Rowena and Joe Salas, joined together at the Oscar Swan Inn ...
(Date:9/3/2015)... ... September 03, 2015 , ... While bariatric surgeon Michael Feiz, M.D., ... when preparing for a bariatric procedure, some patients have been recently asking further questions ... instructions typical for many types of surgery that should be followed in the days ...
(Date:9/3/2015)... ... 2015 , ... TransPack Toon gives users a set of 90 cartoon transitions ... transitions in 30 different styles. Presets range from snow, underwater, forest, futuristic, city and ... Toon features 90 cartoon transitions from 30 unique styles. Editors can choose between ...
(Date:9/3/2015)... York (PRWEB) , ... September 03, 2015 , ... William ... William Mattar, Esq. believes this does not stop at any certain demographic or ... to its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The closed ...
(Date:9/3/2015)... ... September 03, 2015 , ... E-Volve Health, an Elliot ... healthcare solutions organization, to provide electronic medical record (EMR) consulting services to Amerinet ... will receive negotiated pricing on E-Volve Health’s Epic EMR consulting, custom training and ...
Breaking Medicine News(10 mins):Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2
... Feb. 17 HotHead Technologies, Inc. today,announced that the ... results by Kennesaw State University researchers as ... "It,s exciting news that research from a ... able to verify much earlier than we anticipated, in,the ...
... - Awards Confirm Elsevier,s Leadership in Medical E-Products and Books ... - Elsevier,s Procedures Consult Named Top E-Product , ... and medical,information products and services, today announced that it has ... Division of the,Association of American Publishers (AAP). , ...
... Inc. (MED3OOO), a privately held national healthcare management ... as an Applications Systems Provider (ASP) for physicians ... Girardeau, MO. MED3OOO is also providing the hospital ... services through the implementation of advanced reporting tools ...
... 17 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc. (BMR.TSX), provided ... GLASS-ART Trial testing Neuradiab(R) in the most advanced ... that its Board of Directors has recommended a ... market conditions and new projections of site initiation ...
... and FLORHAM PARK, N.J., Feb. 17 Shionogi & ... of velneperit, a novel neuropeptide Y (NPY) Y5 receptor ... endpoint of demonstrating a statistically significant reduction in body ... for the NPY Y5 receptor as a target for ...
... Frost & Sullivan to Host Quarterly Analyst Briefing ... The Chemicals Group at Frost & ... Quarterly Analyst Briefing Presentation on Medical Trends Impacting ... on Thursday, 26 February, 2009 at 3 p.m. ...
Cached Medicine News:Health News:HotHead Technologies' Heat Sensor Shows Exciting Potential by Kennesaw State University Researchers 2Health News:Elsevier Titles Win Four PROSE Awards From Association of American Publishers 2Health News:Elsevier Titles Win Four PROSE Awards From Association of American Publishers 3Health News:Saint Francis Medical Center Physician Services Implements MED3OOO RCM and ASP Services 2Health News:Saint Francis Medical Center Physician Services Implements MED3OOO RCM and ASP Services 3Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 2Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 3Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 4Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 2Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 3Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 4Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 5Health News:Shionogi Announces Positive Top-Line Efficacy Results from Year-Long Studies of Velneperit, a Novel NPY Y5 Receptor Antagonist Being Investigated for the Treatment of Obesity 6Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 2Health News:Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets 3
(Date:9/3/2015)... , Sept. 3, 2015 ... devices market? Which areas are going to grow at ... potential revenues to 2025, assessing data, trends, opportunities and ... tables, charts, and graphs. Discover the most lucrative areas ... new study lets you assess forecasted sales at overall ...
(Date:9/3/2015)... 3, 2015 With a population of more ... and therefore also its single largest potential market for ... has led all major world economies in the average ... and government health expenditures. As an in vitro diagnostics ... of the United States, western European countries, and Japan. ...
(Date:9/3/2015)... About self-monitoring blood glucose device ... device. It consists of a glucose sensor and ... through radiowaves from the sensor to a receiver, ... self-monitoring blood glucose devices can improve self-management of ... diabetes treatment. Technavio,s analysts forecast the ...
Breaking Medicine Technology:Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
... , CAMBRIDGE, Mass. and TOKYO, Dec. 1 ... the further extension of their research and development collaboration ... term to seven years and brings the total committed ... been working together since January 2005 with the goal ...
... , LANSING, Mich., Dec. 1 Neogen Corporation ... the BioKits food safety business of San Diego, Calif.-based Gen-Probe ... kits for food allergens, meat and fish speciation, and plant ... of Tepnel Life Sciences plc in April 2009. Gen-Probe elected ...
Cached Medicine Technology:Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3Neogen Acquires Gen-Probe's BioKits Food Safety Business 2
The DePuy ACE Titanium Active Compression Plate offers ingenuity in the art of fracture management....
Coronet Vacuum Trephine - All metal, ergonomic design and ultra sharp blade with cross hairs....
Corneal Trephine Punch - Stainless steel unit with titanium jaws, complete with PTFE cutting block. 1 reusable unit....
Coronet Donor Punch Set - Unique design providing precise control and full visualization throughout the procedure. Corneal marking pen included....
Medicine Products: